Salomon A. Tendler

Oncology

353 E 68th St
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Prognostic impact of the 9th vs 8th TNM classification in small-cell lung cancer. a population-based study.

Prognostic impact of the 9th vs 8th TNM classification in small-cell lung cancer. a population-based study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 12, 2026

Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers.

Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 02, 2026

Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.

Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.

Journal: JCO precision oncology

Published: November 20, 2025

Delta-like Ligand 3-Directed 225Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models.

Delta-like Ligand 3-Directed 225Ac Radioimmunotherapy in Neuroendocrine Lung and Prostate Cancer Models.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: September 24, 2025

Real-World Evidence of Treatment Outcomes in Small Cell Lung Cancer: A Bayesian Mixed Effects and Competitive Risk Approach.

Real-World Evidence of Treatment Outcomes in Small Cell Lung Cancer: A Bayesian Mixed Effects and Competitive Risk Approach.

Journal: JMIR cancer

Published: September 13, 2025

Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms.

Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms.

Journal: medRxiv : the preprint server for health sciences

Published: July 16, 2025

Emerging importance of HER3 in tumorigenesis and cancer therapy.

Emerging importance of HER3 in tumorigenesis and cancer therapy.

Journal: Nature reviews. Clinical oncology

Published: February 24, 2025

Exploring the discrepancies between clinical trials and real-world data: A small-cell lung cancer study.

Exploring the discrepancies between clinical trials and real-world data: A small-cell lung cancer study.

Journal: Clinical and translational science

Published: April 29, 2024

First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate.

First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate.

Journal: medRxiv : the preprint server for health sciences

Published: January 23, 2024

Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial.

Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial.

Journal: The Lancet. Oncology

Published: January 12, 2024

Application of Process Mining for Modelling Small Cell Lung Cancer Prognosis.

Application of Process Mining for Modelling Small Cell Lung Cancer Prognosis.

Journal: Studies in health technology and informatics

Published: May 19, 2023

Tarlatamab: New Star on the Horizon for Small-Cell Lung Cancer?

Tarlatamab: New Star on the Horizon for Small-Cell Lung Cancer?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 25, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026